Takeda Sheds Multilab In Brazil As Strategic Priorities Shift

Takeda is selling its Multilab operation in Brazil, in a reversal of a deal to buy the mid-sized company around six years ago to bolster its position and generic/OTC portfolios in the country.

BrazilianPill_1200x675
TAKEDA SELLS MULTILAB AS PRIORITIES SHIFT • Source: Shutterstock

In a reversal of a past acquisition, Takeda Pharmaceutical Co. Ltd. is to fully divest all its shares and assets in Multilab Indústria e Comércio de Produtos Farma in Brazil to Novamed, part of the Brazilian NC Group that also owns several of the other large pharma firms in the country such as EMS and Germed.

The move appears to be in line with the leading Japanese pharma firm’s stated desire to focus more on its...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip